![Jeffrey Dayno](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Dayno
Amministratore Delegato presso HARMONY BIOSCIENCES HOLDINGS, INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Jeffrey Dayno
Società | Posizione | Inizio | Fine |
---|---|---|---|
HARMONY BIOSCIENCES HOLDINGS, INC. | Direttore/Membro del Consiglio | 24/04/2023 | - |
Amministratore Delegato | 06/01/2023 | - | |
Presidente | 06/01/2023 | - | |
Direttore Tecnico/Scientifico/R&S | 01/11/2017 | 24/04/2023 | |
Atrin Pharmaceuticals LLC
![]() Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Direttore/Membro del Consiglio | 16/11/2016 | - |
Emalex Biosciences, Inc.
![]() Emalex Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emalex Biosciences, Inc. is a biopharmaceutical company. It focuses on the new and novel treatments for patients with central nervous system disorders. The company was founded by Jeffrey S. Aronin and is headquartered in Chicago, IL. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jeffrey Dayno
Precedenti posizioni note di Jeffrey Dayno
Società | Posizione | Inizio | Fine |
---|---|---|---|
ZYLA LIFE SCIENCES | Direttore Tecnico/Scientifico/R&S | 31/07/2014 | 01/10/2017 |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Direttore Tecnico/Scientifico/R&S | 01/08/2011 | 01/05/2014 |
Viropharma, Inc. | Corporate Officer/Principal | 01/08/2011 | 01/01/2014 |
Labopharm, Inc.
![]() Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Direttore Tecnico/Scientifico/R&S | 06/05/2010 | 01/07/2011 |
Delaware Valley Stroke Council | Presidente | - | - |
Fondatore | - | - | |
Labopharm USA, Inc. | Presidente | 27/01/2011 | - |
░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░ ░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Jeffrey Dayno
Trinity College (Connecticut) | Undergraduate Degree |
Temple University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 14 |
Canada | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 7 |
Director/Board Member | 3 |
President | 2 |
Settori
Health Technology | 9 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
HARMONY BIOSCIENCES HOLDINGS, INC. | Health Technology |
Aziende private | 10 |
---|---|
Labopharm, Inc.
![]() Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Jefferson Health Systems Stroke Center Network | |
Labopharm USA, Inc. | |
Zyla Life Sciences LLC
![]() Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
Atrin Pharmaceuticals LLC
![]() Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Health Technology |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Delaware Valley Stroke Council | |
Emalex Biosciences, Inc.
![]() Emalex Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emalex Biosciences, Inc. is a biopharmaceutical company. It focuses on the new and novel treatments for patients with central nervous system disorders. The company was founded by Jeffrey S. Aronin and is headquartered in Chicago, IL. | Health Technology |
Viropharma, Inc. |
- Borsa valori
- Insiders
- Jeffrey Dayno
- Esperienza